HU0000790D0 - Stabilized medicaments containing hmg-coa reductase inhibitor and process for producing them - Google Patents

Stabilized medicaments containing hmg-coa reductase inhibitor and process for producing them

Info

Publication number
HU0000790D0
HU0000790D0 HU0000790A HU0000790A HU0000790D0 HU 0000790 D0 HU0000790 D0 HU 0000790D0 HU 0000790 A HU0000790 A HU 0000790A HU 0000790 A HU0000790 A HU 0000790A HU 0000790 D0 HU0000790 D0 HU 0000790D0
Authority
HU
Hungary
Prior art keywords
stabilized
producing
coa reductase
reductase inhibitor
medicaments containing
Prior art date
Application number
HU0000790A
Other languages
Hungarian (hu)
Other versions
HU221849B1 (en
Inventor
Mohan B Kabadi
Richard Victor Vivilecchia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from HU9203780A external-priority patent/HU217629B/en
Publication of HU0000790D0 publication Critical patent/HU0000790D0/en
Publication of HU221849B1 publication Critical patent/HU221849B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
HU0000790A 1991-12-12 1992-11-30 Stabilized medicaments containing hmg-coa reductase inhibitor fluvastatin HU221849B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80566791A 1991-12-12 1991-12-12
HU9203780A HU217629B (en) 1991-12-12 1992-11-30 Process for producing stabilized pharmaceutical compositions comprising fluvastatin

Publications (2)

Publication Number Publication Date
HU0000790D0 true HU0000790D0 (en) 2000-04-28
HU221849B1 HU221849B1 (en) 2003-02-28

Family

ID=40794725

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000790A HU221849B1 (en) 1991-12-12 1992-11-30 Stabilized medicaments containing hmg-coa reductase inhibitor fluvastatin

Country Status (8)

Country Link
AT (1) AT401872B (en)
DE (1) DE4245089B4 (en)
HU (1) HU221849B1 (en)
MY (1) MY108187A (en)
NZ (1) NZ270729A (en)
SA (1) SA93130414B1 (en)
TW (1) TW221377B (en)
UA (1) UA39852C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242003B1 (en) * 2000-04-13 2001-06-05 Novartis Ag Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability

Also Published As

Publication number Publication date
ATA190595A (en) 1996-05-15
MY108187A (en) 1996-08-30
DE4245089B4 (en) 2009-07-30
TW221377B (en) 1994-03-01
AT401872B (en) 1996-12-27
SA93130414B1 (en) 2004-08-14
HU221849B1 (en) 2003-02-28
UA39852C2 (en) 2001-07-16
NZ270729A (en) 1995-11-27

Similar Documents

Publication Publication Date Title
HUT63328A (en) Process for producing stabilized pharmaceutical compositions comprissing hmg-coa reductase inhibitor
AU8055594A (en) Process for producing simvastatin and analogs thereof
AU656786B2 (en) Procedure for producing pasteups of structured documents
HU9202353D0 (en) Method for producing trifluoro-methyl-benzyl-phosphonate derivatives and pharmaceutical preparatives containing said compounds
HU9204173D0 (en) Method for producing compounds being applicable for simultaneous inhibiting of no-syntase and cyclogenase
HUT64366A (en) Process for producing hiv-protease inhibitor compounds and pharmaceutical preparatives containing them
HU912432D0 (en) Process for producing substituted azoles and pharmaceutical preparatives containing said compounds
HU9301714D0 (en) Method for producing benmzimidazole derivatives and pharmaceutical preparatives containing said compounds
EP0572680A4 (en) Process for producing rosin ester and colorless rosin
ZA925946B (en) Tetrahydroindazole tetrahydrocyclopentapyrazole and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors
HU9202139D0 (en) Method for producing pyrrholo-pyrazines and pharmaceutical preparatives containing said compounds
IL86463A0 (en) Phosphorus-containing hmg-coa reductase inhibitor compounds and pharmaceutical compositions containing the same
AU1963392A (en) Process and device for manufacturing synthesis gas and application
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
HU9401347D0 (en) Policyclic compounds and process for producing them
HU0000790D0 (en) Stabilized medicaments containing hmg-coa reductase inhibitor and process for producing them
HUT71775A (en) Carriage package from maxibag and process for producing of carriage package
HU9301580D0 (en) Phenyl-furoxanes and methods for producing said compounds and pharmaceutical preparatives containing them
HU9400404D0 (en) Substituted imidazo-benzoxazin-1-one derivatives and process for producing them
EP0320052A3 (en) Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors
HUP9801228A3 (en) Substituted phenyl amidines and medicaments containing these compounds and process for producing them
HU9203899D0 (en) Method for producing spiro-oxindole derivatives and pharmaceutical preparatives containing them
EP0556630A3 (en) Process for the synthesis of exomethylenecephams
IL132987A0 (en) Method for producing medicaments containing hmg-coa reductase inhibitors
HU9302649D0 (en) Process for producing 6-difluoro-methylen-anrosten-one derivatives and pharmaceutical preparatives containing them

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20021206